TFS Trial Form Support vient d’obtenir l’agrément Crédit d’Impôt Recherche (CIR) auprès du ministère en charge de la recherche pour ses travaux de recherche et de développement effectués pour ses…
Read More
[August 2021] Study results available First results from the COVID-Real study were published in BMJ https://www.ohdsi.org/bmj-drug-utilization-study/ This RWE study by TFS jointly with IOMED and OHDSI, describes 2,686 patients hospitalized…
Dear Customers and Vendors, As Chief Executive Officer at TFS, I wanted to take the opportunity to explain to you our approach to recent developments regarding the Coronavirus (COVID-19). Firstly,…
TFS attends ADCM Conference to present a TrialOnline ePRO – a custom patient retention tool developed in successful partnership between a CRO, EDC vendor and pharma. Patient retention represents an…
TFS continues to recognize the importance of partnerships in the clinical development and brings together biotech industry expert, investors and clinical research professionals to discuss the changing landscape of biopharma….
TFS, a leading mid-size CRO providing clinical development solutions to biopharmaceutical companies, joins Medidata Partner Program and combines its therapeutic expertise with leading-edge technologies. TFS has been accredited to the…
Dr. Bassem Saleh new Chief Executive Officer of TFS The Board of Directors of TFS, a leading mid-size CRO providing clinical development solutions to biopharmaceutical companies, appointed Dr. Bassem Saleh…
On September 19th, TFS hosted a seminar in Medicon Village starting a much needed discussion about the changes impacting the biopharmaceutical industry. Representatives from the biotech, academic and investor community…
On January 14, 2019, it was announced that Ratos acquires remaining shares in TFS. This acquisition is a natural next step of the change in ownership structure that started two…